The Native Antigen Company is part of LGC Clinical Diagnostics - Learn More

0 Items
Select Page
A Spotlight on Effective Parental Care: TORCH Serology

A Spotlight on Effective Parental Care: TORCH Serology

TORCH is an acronym representing a group of infectious agents that typically cause mild and treatable diseases in healthy individuals, however, if acquired during pregnancy, they pose a risk of severe birth defects and fetal death. Recognizing maternal infections and...
New Tools for HIV Diagnosis

New Tools for HIV Diagnosis

Enabling a new generation of Human Immunodeficiency Virus 1 (HIV-1) and HIV-2 diagnostic assays and structural studies Sensitive and accessible diagnostics and medication remain the only tools to tame the spread and protect the population from the life-limiting...
HITTING A MOVING TARGET

HITTING A MOVING TARGET

By Holge Hannemann, Director of Research, The Native Antigen Company Influenza viruses A and B are a major public health concern, mainly affecting the pharynx, trachea, and sometimes the lungs of millions of people worldwide each year, with symptoms that range from...
The Native Antigen Company will be exhibiting at MEDICA

The Native Antigen Company will be exhibiting at MEDICA

The Native Antigen Company will be exhibiting at MEDICA in Dϋsseldorf, Germany, 14-17 November at Hall 3 Booth 3H42 as part of the LGC Clinical Diagnostics Group. Please come and speak with one of our Experts at our booth. In line with the theme of this year’s event,...
Monkeypox; 3 months on

Monkeypox; 3 months on

It has been 3 months since a new, unusually widespread outbreak of Monkeypox was first identified. What was normally a virus confined to limited infections in the West African continent is becoming a global health concern.   What have we learned about this virus...